3D-printed implant maker Restor3d announced today that it completed a funding round, bringing in proceeds totaling $38 million. Durham, North Carolina-based Restor3d received funds from both existing and new private investors, including Summers Value Partners. It plans to use the money to fuel its continued growth and launch four new 3D-printed product lines in 2025 […]
Restor3d
Restor3d expands into robotics, navigation with new leadership appointments
Restor3d announced today that it made two new leadership appointments to spearhead a strategic expansion into robotics and navigation. The orthopedic technology company named Larry Hazbun SVP of robotics and Kirstin Widding SVP of hip & knee. Durham, North Carolina-based Restor3d, a 3D-printed orthopedic implant maker, offers patient-specific, patient-matched, and associated ancillary products. Its expertise […]
Restor3D secures $70M in financing round
Restor3d has successfully closed a funding round worth $70 million. The Series A funding round brought in $55 million and was led by private investors, including Summers Value Partners and existing partners. It also added $15 million in debt financing, led by Trinity Capital. The company plans to use the proceeds to grow innovation in […]
3D-printed orthopedic implant maker Restor3d completes Conformis acquisition
Restor3d announced today that it completed its previously announced acquisition of Conformis (Nasdaq:CFMS). The companies completed the deal, announced in June, after Conformis’ stockholders approved it at a special meeting on Aug. 31. As a result, shares of Conformis common stock ceased trading on the Nasdaq prior to market open today, Sept. 5. Per the […]
Restor3d to acquire Conformis for $2.27 per share
Restor3d and Conformis (Nasdaq:CFMS) announced that they entered into a definitive merger agreement. Under the agreement, Restor3d, a 3D-printed orthopedic implants company, acquires all outstanding shares of Conformis common stock. The deal includes a purchase price of $2.27 per share. That represents a 96% premium to the closing price on June 22, 2023. Restor3d intends […]
FDA clears patient-specific resection for the Restor3d Axiom total ankle
Restor3d received FDA 510(k) clearance for its Axiom patient-specific resection (PSR) system for use with its Kinos Axiom Total Ankle system. Durham, North Carolina-based Restor3d additively manufactures the Axiom PSR from titanium alloy. The company said this makes it the first all-metal, patient-specific instrumentation system cleared for use with an ankle arthroplasty system. According to […]
